Bill > HB533

This bill expands the types of single-dose epinephrine delivery systems that public schools and other authorized entities can use to treat life-threatening allergic reactions, known as anaphylaxis. The changes clarify that these systems, which are approved by the U.S. Food and Drug Administration (FDA) and contain a pre-measured dose of epinephrine, can be administered by trained school personnel or designated employees of authorized entities, such as camps or sports leagues, even if the individual experiencing the reaction does not have a prescription. The bill also updates definitions and clarifies immunity provisions for those who administer or provide these life-saving devices, ensuring that individuals acting in good faith are protected from civil liability unless their actions are willfully or wantonly negligent.

Health and Social Services

https://alison.legislature.state.al.us/bill-search